REG - Avingtrans PLC - Exercise of Options, PDMR Dealings & TVR

AvingtransAnnouncement

21/03/2024 17:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240321:nRSU8578Ha&default-theme=true

RNS Number : 8578H  Avingtrans PLC  21 March 2024

21 March 2024

Avingtrans Plc

 

("Avingtrans", the "Company", or the "Group")

 

Exercise of Options, PDMR Dealings and Total Voting Rights

 

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical
components, modules, systems and associated services to the energy, medical
and industrial sectors, announces transactions involving its shares by certain
PDMRs and other employees pursuant to the Company Share Option plan ("CSOP").

 

On 20 March 2024, the Company was notified of the exercise of 192,400 CSOP
options over ordinary shares of 5p each in the Company ("Ordinary Shares")
pursuant to the Company's FY 2019 CSOP and FY 2020 CSOP.

 

Details of the exercise of options by PDMRs, together with subsequent
beneficial holdings of each individual following the transactions, are set out
below:

 

 PDMR / Role                                                    CSOP options exercised  Beneficial interest in Ordinary Shares following the transactions  Resulting percentage holding of Enlarged Total Voting Rights held
 Stephen King (CFO)                                             10,400                  417,338                                                            1.27%
 Austen Adams (MD, Process Solutions & Rotating Equipment)      110,000                 263,135                                                            0.80

 

Issue of Equity

 

Application has been made for the admission to trading on AIM for the
192,400 new Ordinary Shares ("Admission"). It is expected that Admission will
become effective on 26 March 2024.

 

Total Voting Rights

 

Following the issue of the 192,400 new Ordinary Shares, the Company will have
a total of 33,089,922 Ordinary Shares in issue. The Company does not hold any
shares in Treasury.

 

The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.

 

The above information is provided by the Company in accordance with its
obligations under the FCA's Disclosure Guidance and Transparency Rules.

 

ENDS

 

 

Enquiries:

 

 Avingtrans plc                                          01354 692391

 Les Thomas, Interim Chairman

 Steve McQuillan, Chief Executive Officer

 Stephen King, Chief Financial Officer

 Singer Capital Markets (Nominated Adviser and Broker)   02074 963000

 Shaun Dobson

 Alex Bond

 Oliver Platts

 IFC Advisory (Financial PR)                             020 3934 6630

 Graham Herring

 Tim Metcalfe

 Zach Cohen

 

 

 

About Avingtrans plc:

Avingtrans designs, manufactures and supplies original equipment, systems and
associated aftermarket services to the energy, medical and industrial markets
worldwide.

Business units

 Hayward Tyler - Luton, East Kilbride & Nottingham, UK, USA, China and
 India

 Specialises in the design, manufacture and servicing of performance-critical
 motors and pumps for challenging environments.

 Energy Steel, Inc - Rochester Hills, Michigan, USA

 Provider of custom fabrications for the nuclear industry, specialising in: OEM
 parts obsolescence; custom fabrications; engineering design solutions; product
 refurbishment; on-site technical support.

 Stainless Metalcraft Ltd - Chatteris, UK

 Provider of safety-critical equipment for the energy, medical, science and
 research communities, worldwide, specialising in precision pressure and vacuum
 vessels and associated fabrications, sub-assemblies and systems.

 Booth Industries - Bolton, UK

 Designs, manufactures, installs and services doors and walls which can be
 tailored to be: blast and explosion proof; fireproof; acoustically shielded;
 high security/safety; or combinations of the above.

 Ormandy Group - Bradford, UK

 Design, manufacturers and servicing of off-site plant, heat exchangers and
 other HVAC (heating, ventilation and air conditioning) products.

 Composite Products Ltd - Buckingham, UK

 Centre for composite technology, parts and assemblies, serving customers in
 industrial markets.

 Adaptix Ltd - Oxford, UK

 Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary
 applications amongst others. Commercialisation of this system (and others) is
 on-going.

 Magnetica Ltd - Brisbane, Australia

 Magnetica Limited specialises in the development of next generation MRI
 technologies, including dedicated extremity MRI systems and MRI system
 components. Magnetica has successfully built and tested a compact, integrated
 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging.
 Commercialisation of this system (and others) is on-going. Magnetica's
 structure now includes two other business units:

 Scientific Magnetics - Abingdon, UK

 Designs and manufactures superconducting magnet systems and associated
 cryogenics for a variety of markets including MRI and provides services for
 Nuclear Magnetic Resonance instruments.

 Tecmag Inc - Houston, USA

 Designs, manufactures and installs instrumentation, including consoles, system
 upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear
 Magnetic Resonance (NMR) systems.

1  Details of the person discharging managerial responsibilities / person closely
    associated

 a)   Name                                                         Steve King

 2  Reason for the notification

 a)   Position/status                                              CFO

      Initial notification /Amendment                              Initial notification

 3  Details of the issuer, emission allowance market participant, auction

  platform, auctioneer or auction monitor

 a)   Name                                                         Avingtrans PLC

 b)   LEI                                                          213800ZZ96CKPI423E86

 4  Details of the transaction(s): section to be repeated for (i) each type of

  instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  CSOP Option Awards over Ordinary Shares of 5p each

    Identification code                                          ISIN: GB0009188797

 b)   Nature of the transaction                                    Exercise of Options under the CSOP

 c)   Price(s) and volume(s)

 Price(s)  Volume(s)

                                                                                     267p      10,400

 d)   Aggregated information                                       n/a

    - Aggregated volume

    - Price

 e)   Date of the transaction                                      20 March 2024

 f)   Place of the transaction                                     Off market

 

 d)

 Aggregated information

 n/a

 - Aggregated volume

- Price

e)

 Date of the transaction

 20 March 2024

 f)

 Place of the transaction

 Off market

1  Details of the person discharging managerial responsibilities / person closely
    associated

 a)   Name                                                         Austen Adams

 2  Reason for the notification

 a)   Position/status                                              MD, Process Solutions & Rotating Equipment

      Initial notification /Amendment                              Initial notification

 3  Details of the issuer, emission allowance market participant, auction

  platform, auctioneer or auction monitor

 a)   Name                                                         Avingtrans PLC

 b)   LEI                                                          213800ZZ96CKPI423E86

 4  Details of the transaction(s): section to be repeated for (i) each type of

  instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  CSOP Option Awards over Ordinary Shares of 5p each

    Identification code                                          ISIN: GB0009188797

 b)   Nature of the transaction                                    Exercise of Options under the CSOP

 c)   Price(s) and volume(s)

 Price(s)  Volume(s)

                                                                                     267p      110,000

 d)   Aggregated information                                       n/a

    - Aggregated volume

    - Price

 e)   Date of the transaction                                      20 March 2024

 f)   Place of the transaction                                     Off market

 

 d)

 Aggregated information

 n/a

 - Aggregated volume

- Price

e)

 Date of the transaction

 20 March 2024

 f)

 Place of the transaction

 Off market

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

20 March 2024

f)

 

Place of the transaction

 

 

Off market

 

 1    Details of the person discharging managerial responsibilities / person closely
      associated

 a)   Name                                                         Austen Adams

 2    Reason for the notification

 a)   Position/status                                              MD, Process Solutions & Rotating Equipment

      Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Avingtrans PLC

 b)   LEI                                                          213800ZZ96CKPI423E86

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  CSOP Option Awards over Ordinary Shares of 5p each

      Identification code                                          ISIN: GB0009188797

 b)   Nature of the transaction                                    Exercise of Options under the CSOP

 c)   Price(s) and volume(s)

Price(s)  Volume(s)

                                                                                     267p      110,000

 

 d)   Aggregated information                                       n/a

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      20 March 2024

 f)   Place of the transaction                                     Off market

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

20 March 2024

f)

 

Place of the transaction

 

 

Off market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFERVTILFIS